Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Takyi-Williams

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Evaluation of [<sup>68</sup>Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial InfectionsPalesa C Koatale, Mick M Welling, Sipho Mdanda, et al.
Bioanalysis|November 22, 2023
Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill childrenJohn Takyi-Williams, Abbie D Leino, Ruiting Li, et al.
Journal of Medicinal Chemistry|March 13, 2024
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor RegressionZhixiang Chen, Mi Wang, Dimin Wu, et al.
Scientific Reports|November 1, 2025
Pan-cancer Myc modulator that targets Myc-α-tubulin interaction to drive selective mitotic catastropheJessica Teitel, Margaret Farah, Michele L Dziubinski, et al.
Journal of Medicinal Chemistry|June 29, 2023
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate CancerXin Han, Lijie Zhao, Weiguo Xiang, et al.
Journal of Medicinal Chemistry|September 8, 2023
Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate CancerWeiguo Xiang, Lijie Zhao, Xin Han, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Evaluation of [<sup>68</sup>Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial InfectionsPalesa C Koatale, Mick M Welling, Sipho Mdanda, et al.
Bioanalysis|November 22, 2023
Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill childrenJohn Takyi-Williams, Abbie D Leino, Ruiting Li, et al.
Journal of Medicinal Chemistry|March 13, 2024
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor RegressionZhixiang Chen, Mi Wang, Dimin Wu, et al.
Scientific Reports|November 1, 2025
Pan-cancer Myc modulator that targets Myc-α-tubulin interaction to drive selective mitotic catastropheJessica Teitel, Margaret Farah, Michele L Dziubinski, et al.
Journal of Medicinal Chemistry|June 29, 2023
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate CancerXin Han, Lijie Zhao, Weiguo Xiang, et al.
Journal of Medicinal Chemistry|September 8, 2023
Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate CancerWeiguo Xiang, Lijie Zhao, Xin Han, et al.
Pageof 2